In line with this concept, Teff-derived TNFa has been shown to boost Tregs, dependent upon TNFR2 expression on Tregs, in experimental models of diabetes (95) and graft-vs-host disease (GvHD) (96). The gene discussed is TNF; the disease is diabetes mellitus.